APOL1 was found to be overexpressed in pancreatic cancer, lung adenocarcinoma and papillary thyroid carcinomas compared to matched normal tissues, and it was found to have prognostic value for pancreatic cancer and lung adenocarcinoma [28–30]. Here, APOL1 is linked to lung adenocarcinoma.